Christian Simader1, Ramzi G Sayegh2, Alessio Montuoro3, Malek Azhary3, Anna Lucia Koth3, Magdalena Baratsits4, Stefan Sacu4, Christian Prünte4, David P Kreil5, Ursula Schmidt-Erfurth1. 1. Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. 2. Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Vienna, Austria; Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. Electronic address: ramzi.sayegh@meduniwien.ac.at. 3. Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. 4. Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. 5. Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria; School of Life Sciences, University of Warwick, Coventry, UK.
Abstract
PURPOSE: To identify reliable criteria based on spectral-domain optical coherence tomography (SD OCT) to monitor disease progression in geographic atrophy attributable to age-related macular degeneration (AMD) compared with lesion size determination based on fundus autofluorescence (FAF). DESIGN: Prospective longitudinal observational study. METHODS: setting: Institutional. study population: A total of 48 eyes in 24 patients with geographic atrophy. observation procedures: Eyes with geographic atrophy were included and examined at baseline and at months 3, 6, 9, and 12. At each study visit best-corrected visual acuity (BCVA), FAF, and SD OCT imaging were performed. FAF images were analyzed using the region overlay device. Planimetric measurements in SD OCT, including alterations or loss of outer retinal layers and the RPE, as well as choroidal signal enhancement, were performed with the OCT Toolkit. main outcome measures: Areas of interest in patients with geographic atrophy measured from baseline to month 12 by SD OCT compared with the area of atrophy measured by FAF. RESULTS: Geographic atrophy lesion size increased from 8.88 mm² to 11.22 mm² based on quantitative FAF evaluation. Linear regression analysis demonstrated that results similar to FAF planimetry for determining lesion progression can be obtained by measuring the areas of outer plexiform layer thinning (adjusted R(2) = 0.93), external limiting membrane loss (adjusted R(2) = 0.89), or choroidal signal enhancement (R(2) = 0.93) by SD OCT. CONCLUSIONS: SD OCT allows morphologic markers of disease progression to be identified in geographic atrophy and may improve understanding of the pathophysiology of atrophic AMD.
PURPOSE: To identify reliable criteria based on spectral-domain optical coherence tomography (SD OCT) to monitor disease progression in geographic atrophy attributable to age-related macular degeneration (AMD) compared with lesion size determination based on fundus autofluorescence (FAF). DESIGN: Prospective longitudinal observational study. METHODS: setting: Institutional. study population: A total of 48 eyes in 24 patients with geographic atrophy. observation procedures: Eyes with geographic atrophy were included and examined at baseline and at months 3, 6, 9, and 12. At each study visit best-corrected visual acuity (BCVA), FAF, and SD OCT imaging were performed. FAF images were analyzed using the region overlay device. Planimetric measurements in SD OCT, including alterations or loss of outer retinal layers and the RPE, as well as choroidal signal enhancement, were performed with the OCT Toolkit. main outcome measures: Areas of interest in patients with geographic atrophy measured from baseline to month 12 by SD OCT compared with the area of atrophy measured by FAF. RESULTS:Geographic atrophylesion size increased from 8.88 mm² to 11.22 mm² based on quantitative FAF evaluation. Linear regression analysis demonstrated that results similar to FAF planimetry for determining lesion progression can be obtained by measuring the areas of outer plexiform layer thinning (adjusted R(2) = 0.93), external limiting membrane loss (adjusted R(2) = 0.89), or choroidal signal enhancement (R(2) = 0.93) by SD OCT. CONCLUSIONS: SD OCT allows morphologic markers of disease progression to be identified in geographic atrophy and may improve understanding of the pathophysiology of atrophic AMD.
Authors: Emma C Zanzottera; Jeffrey D Messinger; Thomas Ach; R Theodore Smith; K Bailey Freund; Christine A Curcio Journal: Invest Ophthalmol Vis Sci Date: 2015-05 Impact factor: 4.799
Authors: Emma C Zanzottera; Thomas Ach; Carrie Huisingh; Jeffrey D Messinger; Richard F Spaide; Christine A Curcio Journal: Retina Date: 2016-12 Impact factor: 4.256
Authors: Diane L Wang; Julia Agee; Marco Mazzola; Riccardo Sacconi; Giuseppe Querques; Alan D Weinberg; R Theodore Smith Journal: Ophthalmol Retina Date: 2019-08-07
Authors: Patricia T A Bui; Gregor S Reiter; Maria Fabianska; Sebastian M Waldstein; Christoph Grechenig; Hrvoje Bogunovic; Mustafa Arikan; Ursula Schmidt-Erfurth Journal: Eye (Lond) Date: 2021-08-16 Impact factor: 4.456
Authors: Christopher Schütze; Katharina Teleky; Bernhard Baumann; Michael Pircher; Erich Götzinger; Christoph K Hitzenberger; Ursula Schmidt-Erfurth Journal: Br J Ophthalmol Date: 2015-07-16 Impact factor: 4.638
Authors: Christine A Curcio; Emma C Zanzottera; Thomas Ach; Chandrakumar Balaratnasingam; K Bailey Freund Journal: Invest Ophthalmol Vis Sci Date: 2017-05-01 Impact factor: 4.799